These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 31500623)
1. LncRNA PLAC 2 downregulated miR-21 in non-small cell lung cancer and predicted survival. Xia H; Xiu M; Gao J; Jing H BMC Pulm Med; 2019 Sep; 19(1):172. PubMed ID: 31500623 [TBL] [Abstract][Full Text] [Related]
2. IncRNA PLAC2 Upregulates CDK6 by Directly Targeting miR-29C to Promote Cell Proliferation in Lung Squamous Cell Carcinoma. Zhao X; He X; Wang M; Zhang H; Cheng J; Wang H Crit Rev Eukaryot Gene Expr; 2022; 32(8):55-67. PubMed ID: 36017916 [TBL] [Abstract][Full Text] [Related]
3. LncRNA PLAC2 upregulates miR-663 to downregulate TGF-β1 and suppress bladder cancer cell migration and invasion. Zhang Z; Ao P; Han H; Zhang Q; Chen Y; Han J; Huang Q; Huang H; Zhuo D BMC Urol; 2020 Jul; 20(1):94. PubMed ID: 32650766 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p. Zeng Q; Dai Y; Duan C; Zeng R; Zeng Q; Wei C BMC Pulm Med; 2020 Jul; 20(1):185. PubMed ID: 32615948 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a. Huang S; Li C; Huang J; Luo P; Mo D; Wang H BMC Pulm Med; 2020 Apr; 20(1):110. PubMed ID: 32349744 [TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival. Liang M; Wang L; Cao C; Song S; Wu F BMC Pulm Med; 2020 Oct; 20(1):273. PubMed ID: 33081752 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression. Guo D; Wang Y; Ren K; Han X Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1. Wei S; Liu J; Li X; Liu X BMC Pulm Med; 2020 Mar; 20(1):78. PubMed ID: 32228546 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of lncRNA XIST inhibits cell proliferation via regulating miR-744/RING1 axis in non-small cell lung cancer. Wang J; Cai H; Dai Z; Wang G Clin Sci (Lond); 2019 Jul; 133(14):1567-1579. PubMed ID: 31292221 [TBL] [Abstract][Full Text] [Related]
10. LncRNA WT1-AS over-expression inhibits non-small cell lung cancer cell stemness by down-regulating TGF-β1. Jiang X; Wang J; Fang L BMC Pulm Med; 2020 Apr; 20(1):113. PubMed ID: 32349718 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764 [TBL] [Abstract][Full Text] [Related]
12. LncRNA TP73-AS1 is upregulated in non-small cell lung cancer and predicts poor survival. Zhu D; Zhou J; Liu Y; Du L; Zheng Z; Qian X Gene; 2019 Aug; 710():98-102. PubMed ID: 31129247 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25. Sui Y; Chi W; Feng L; Jiang J BMC Pulm Med; 2020 Mar; 20(1):59. PubMed ID: 32138716 [TBL] [Abstract][Full Text] [Related]
14. LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival. Wan Y; Yao D; Fang F; Wang Y; Wu G; Qian Y BMC Cancer; 2021 Jan; 21(1):104. PubMed ID: 33514344 [TBL] [Abstract][Full Text] [Related]
15. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway. Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761. Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression. Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417 [TBL] [Abstract][Full Text] [Related]
19. LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer. Cheng D; Bao C; Zhang X; Lin X; Huang H; Zhao L Biomed Pharmacother; 2018 Nov; 107():1540-1547. PubMed ID: 30257372 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in non-small cell lung cancer. Han W; Du X; Liu M; Wang J; Sun L; Li Y Int J Biol Macromol; 2019 Jan; 121():270-278. PubMed ID: 30287374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]